Literature DB >> 34687603

Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.

Chiung-Ying Chang1, Zohar Shipony2, Sherry G Lin1, Ann Kuo1, Xiaochen Xiong3, Kyle M Loh3, William J Greenleaf4, Gerald R Crabtree5.   

Abstract

Mammalian SWI/SNF (BAF) chromatin remodelers play dosage-sensitive roles in many human malignancies and neurologic disorders. The gene encoding the BAF subunit actin-like 6a (ACTL6A) is amplified early in the development of many squamous cell carcinomas (SCCs), but its oncogenic role remains unclear. Here we demonstrate that ACTL6A overexpression leads to its stoichiometric assembly into BAF complexes and drives their interaction and engagement with specific regulatory regions in the genome. In normal epithelial cells, ACTL6A was substoichiometric to other BAF subunits. However, increased ACTL6A levels by ectopic expression or in SCC cells led to near saturation of ACTL6A within BAF complexes. Increased ACTL6A occupancy enhanced polycomb opposition genome-wide to activate SCC genes and facilitated the co-dependent loading of BAF and TEAD-YAP complexes on chromatin. Both mechanisms appeared to be critical and function as a molecular AND gate for SCC initiation and maintenance, thereby explaining the specificity of the role of ACTL6A amplification in SCCs.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACTL6A; BAF complex; SWI/SNF; TEAD; YAP; cancer; chromatin remodeling; polycomb; squamous cell carcinoma; transcription

Mesh:

Substances:

Year:  2021        PMID: 34687603      PMCID: PMC8761479          DOI: 10.1016/j.molcel.2021.10.005

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  96 in total

1.  ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.

Authors:  Srinivas Vinod Saladi; Kenneth Ross; Mihriban Karaayvaz; Purushothama R Tata; Hongmei Mou; Jayaraj Rajagopal; Sridhar Ramaswamy; Leif W Ellisen
Journal:  Cancer Cell       Date:  2016-12-29       Impact factor: 31.743

Review 2.  Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities.

Authors:  Philamer C Calses; James J Crawford; Jennie R Lill; Anwesha Dey
Journal:  Trends Cancer       Date:  2019-05-16

3.  Targeted in situ genome-wide profiling with high efficiency for low cell numbers.

Authors:  Peter J Skene; Jorja G Henikoff; Steven Henikoff
Journal:  Nat Protoc       Date:  2018-04-12       Impact factor: 13.491

4.  YAP and TAZ are essential for basal and squamous cell carcinoma initiation.

Authors:  Maud Debaugnies; Adriana Sánchez-Danés; Sandrine Rorive; Maylis Raphaël; Mélanie Liagre; Marie-Astrid Parent; Audrey Brisebarre; Isabelle Salmon; Cédric Blanpain
Journal:  EMBO Rep       Date:  2018-06-06       Impact factor: 8.807

Review 5.  Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.

Authors:  Daniel R Simpson; Loren K Mell; Ezra E W Cohen
Journal:  Oral Oncol       Date:  2014-12-17       Impact factor: 5.337

6.  brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2.

Authors:  J W Tamkun; R Deuring; M P Scott; M Kissinger; A M Pattatucci; T C Kaufman; J A Kennison
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

7.  Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.

Authors:  K Heselmeyer; E Schröck; S du Manoir; H Blegen; K Shah; R Steinbeck; G Auer; T Ried
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

8.  A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis.

Authors:  Paul Krimpenfort; Margriet Snoek; Jan-Paul Lambooij; Ji-Ying Song; Robin van der Weide; Rajith Bhaskaran; Hans Teunissen; David J Adams; Elzo de Wit; Anton Berns
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

9.  Genome-wide association of Yorkie with chromatin and chromatin-remodeling complexes.

Authors:  Hyangyee Oh; Matthew Slattery; Lijia Ma; Alex Crofts; Kevin P White; Richard S Mann; Kenneth D Irvine
Journal:  Cell Rep       Date:  2013-02-08       Impact factor: 9.423

10.  SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.

Authors:  Wei Yu; Yiming Ma; Sharmila Shankar; Rakesh K Srivastava
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

View more
  4 in total

1.  Distinct interactors define the p63 transcriptional signature in epithelial development or cancer.

Authors:  Rosalba Pecorari; Francesca Bernassola; Gerry Melino; Eleonora Candi
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

2.  ACTL6a coordinates axonal caliber recognition and myelination in the peripheral nerve.

Authors:  Hye-Jin Park; Eric Tsai; Dennis Huang; Michael Weaver; Luciana Frick; Ace Alcantara; John J Moran; Julia Patzig; Carmen V Melendez-Vasquez; Gerald R Crabtree; M L Feltri; John Svaren; Patrizia Casaccia
Journal:  iScience       Date:  2022-03-23

Review 3.  3D chromatin architecture and transcription regulation in cancer.

Authors:  Siwei Deng; Yuliang Feng; Siim Pauklin
Journal:  J Hematol Oncol       Date:  2022-05-04       Impact factor: 23.168

Review 4.  Transcriptional Regulation of the Hippo Pathway: Current Understanding and Insights from Single-Cell Technologies.

Authors:  Sayantanee Paul; Shiqi Xie; Xiaosai Yao; Anwesha Dey
Journal:  Cells       Date:  2022-07-17       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.